Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

2.

Australian researchers attribute drop in melanoma rates to increasingly diverse population

3.

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

4.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

5.

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot